Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia
Clinical trial NCT04972227 · COMPLETED
Trial details
- NCT number
- NCT04972227
- Sponsor
- Tisento Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2022-04-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.